Listeria monocytogenes: A potent vaccine vector for neoplastic and infectious disease

Immunological Reviews

Volumn 158, Issue , 1997, Pages 159-169

  Weiskirch, Larry M ^a   Paterson, Yvonne ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; CELLULAR IMMUNITY; IMMUNE RESPONSE; LISTERIA MONOCYTOGENES; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTIGENS, NEOPLASM; ANTIGENS, VIRAL; CANCER VACCINES; GENETIC VECTORS; LISTERIA MONOCYTOGENES; MICE; VACCINES, SYNTHETIC; VIRAL VACCINES;

EID: 0030880412     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1997.tb01002.x     Document Type: Review

References (48)

1. Cease KB, Berzofsky JA. Towards a vaccine for AIDS: The emergence of immunobiology based vaccine development. Annu Rev Immunol 1994;12:923-989.
2. Paul WE. Re-examining AIDS research priorities. Science 1995;267:633-636.
3. Pardoll DM. Cancer vaccines: A road map for the next decade. Curr Opin Immunol 1996;8:619-621.
4. Ikonomidis G, Frankel FR, Portnoy DA, Paterson Y. Listeria monocytogenes: a novel live vaccine vector. In: Brown F, Charnock R, Ginsberg H, Norrby E, eds. Vaccines 95, Molecular approaches to the control of infectious diseases. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1995.p.317-326.
5. Ikonomidis G, Paterson Y. Recombinant Listeria monocytogenes cancer vaccines. Curr Opin Immunol 1996;8:664-669.
6. Schafer R, Portnoy DA, Brassell SA, Paterson Y. Induction of a cellular immune response to a foreign antigen by a recombinant Listeria monocytogenes vaccine. J Immunol 1992;149:53-59.
7. Ikonomidis G, Paterson Y, Kos FJ, Portnoy DA. Delivery of a viral antigen to the class I processing and presentation pathway by Listeria monocytogenes. J Exp Med 1994;180:2209-2218.
8. Frankel FR, Hegde S, Lieberman J, Paterson Y. Induction of cell-mediated immune responses to human immunodeficiency virus type 1 Gag protein by using Listeria monocytogenes as a live vaccine vector. J Immunol 1995;155:4775-1782.
9. Shen H, Slifka MK, Matloubian M, Jensen ER, Ahmed R, Miller JF. Recombinant Listeria monocytogenes as a live vaccine vehicle for the induction of protective anti-viral cell-mediated immunity. Proc Natl Acad Sci USA 1995;92:3987-3991.
10. Camilli A, Tilney LG, Portnoy DA. Dual roles of plcA in Listeria monocytogenes pathogenesis. Mol Microbiol 1993;8:143-157.
11. Del Val M, Schlicht H-J, Ruppert T, Reddenhase MJ, Kozinovvski U. Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein. Cell 1991;66:1145-1153.
12. Eisenlohr LC, Yewdell JW, Bennink JR. Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes. J Exp Med 1992;175:481-487.
13. + T cells in vivo: A study with the nucleoprotein of the lymphocytic choriomeningitis virus. Int Immunol 1995;7:797-805.
14. Ikonomidis G, Portnoy DA, Gerhard W, Paterson Y. Influenza-specific immunity induced by recombinant Listeria monocytogenes vaccines. Vaccine 1997;15:433-440.
15. Slifka MK, Shen H, Matloubian M, Jensen ER, Miller JF, Ahmed R. Antiviral cytotoxic T-cell memory by vaccination with recombinant Listeria monocytogenes. J Virol 1996;70:2902-2910.
16. Schulz M, et al. Major histocompatibility complex dependent T cell epitopes of lymphocytic choriomeningitis virus nucleoprotein and their protective capacity against viral disease. Eur J Immunol 1989;19:1657-1667.
17. Whitton JL, et al. Molecular analyses of a five-amino-acid cytotoxic T- lymphocyte (CTL) epitope: an immunodominant region which induces nonreciprocal CTL cross-reactivity. J Virol 1989;63:4303-4310.
18. Bodmer HC, Pemberton RM, Rothbard JB, Askonas BA. Enhanced recognition of a modified peptide antigen by cytotoxic T cells specific for influenza nucleoprotein. Cell 1988;52:253-258.
19. Horton RM, Cai Z, Ho SN, Pease LR. Gene splicing by overlap extension. Tailor-made genes using the polymerase chain reaction. Biotechniques 1990;8:528-535.
20. Pamer EG, Harty JT, Bevan MJ. Precise prediction of a dominant class I MHC-restricted epitope of Listeria monocytogenes. Nature 1991;353:852-855.
21. Levy JA. Pathogenesis of human immunodeficiency virus infection. Microbiol Rev 1993;57:183-289.
22. Clerici M, Shearer GM. A Th1 to Th2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993;14:107-111.
23. Graziosi C, et al. Lack of evidence for the dichotomy of Th1 and Th2 predominance in HIV-infected individuals. Science 1994;265:248-252.
24. Mosmann TR. Cytokine patterns during the progression to AIDS. Science 1994;265:193-194.
25. Klein MR, et al. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. J Exp Med 1995;181:1365-1372.
26. + cell response against human immunodeficiency virus: Implications for long-term survival. Proc Natl Acad Sci USA 1995;92: 11135-11139.
27. Salk J, Bretscher PA, Salk PL, Clerici M, Shearer GM. A strategy for prophylactic vaccination against HIV. Science 1993;260:1270-1272.
28. Bourgault I, Chirat F, Tartar A, Levy JP, Guillet JG, Venet A. Simian immunodeficiency virus as a model for vaccination against HIV: Induction in rhesus macaques of Gag- or Nef-specific cytotoxic T lymphocytes by lipopeptides. J Immunol 1994;152:2530-2537.
29. Paul WE, Seder RA. Lymphocyte responses and cytokines. Cell 1994;76:241-251.
30. Mackaness GB. Cellular resistance to infection. J Exp Med 1962;116:381-406.
31. Pan Z-K, Ikonomidis G, Lazenby A, Pardoll D, Paterson Y. A recombinant Listeria monocytogenes vaccine expressing a model tumour antigen protects mice against lethal tumour cell challenge and causes regression of established tumours. Nat Med 1995;1:471-477.
32. Lehmann PV, Sercarz EE, Forsthuber T, Dayan CM. Gammon G. Determinant spreading and the dynamics of the autoimmune T cell repertoire. Immunol Today 1993;14:203-208.
33. Pan Z-K, Ikonomidis G, Pardoll D, Paterson Y. Regression of established tumors in mice mediated by the oral administration of a recombinant Listeria monocytogenes vaccine. Cancer Res 1995;55:4776-4779.
34. Southwick FS, Purich DL. Intracellular pathogenesis of Listeriosis. N Engl J Med 1996;334:770-776.
35. Gellin BG, Broome CV. Listeriosis. JAMA 1989;261:1313-1320.
36. + T lymphocytes by an attenuated Listeria monocytogenes actA mutant. Int Immunol 1992;4:1413-1418.
37. Alexander JE, Andrew PW, Jones D, Roberts IS. Characterization of an aromatic amino acid-dependent Listeria monocytogenes mutant: Attenuation, persistence, and ability to induce protective immunity in mice. Infect Immun 1993;61:2245-2248.
38. Chakraborty T, Ebel F, Wehland J, Dufrenne J, Notermans S. Naturally occurring virulence-attenuated isolates of Listeria monocytogenes capable of inducing long term protection against infection by virulent strains of homologous and heterologous serotypes. FEMS Immunol Med Microbiol 1994;10:1-10.
39. Barry RA, Bouwer HGA, Portnoy DA, Hinrichs DJ. Pathogenicity and immunogenicity of Listeria monocytogenes small-plaque mutants defective for intracellular growth and cell-to-cell spread. Infect Immun 1992;60:1625-1632.
40. Sheehan B, et al. Molecular and genetic determinants of the Listeria monocytogcnes infectious process. Curr Top Microbiol Immunol 1994;192: 187-216.
41. de Vega T, Echevarria S, Crespo J, Artinano E, San Miguel G, Pons Romero F. Acute hepatitis by Listeria monocytogenes in an HIV patient with chronic HBV hepatitis. J Clin Gastroenterol 1992;15:251-255.
42. Decker CF, Simon GL, DiGioia RA, Tuazon CU. Listeria monocytogenes infections in patients with AIDS: Report of five cases and review. Rev Infectious Disease 1991;13:413-417.
43. Falo Jr LD, Kovacsovics-Bankowski M, Thompson K, Rock KL. Targeting antigen into the phagocytic pathway in vivo induces protective tumour immunity. Nat Med 1995;1:649-653.
44. Elson CJ, Barker RN, Thompson SJ, Williams NA. Immunologically ignorant autoreactive T cells, epitope spreading and repertoire limitation. Immunol Today 1995;16:71-76.
45. Robbins PF, Kawakami Y. Human tumor antigens recognized by T cells. Curr Opin Immunol 1996;8:628-636.
46. Tindle RW. Human papillomavirus vaccines for cervical cancer. Curr Opin Immunol 1996;8:643-650.
47. Disis ML, Cheever MA. Oncogenic proteins as tumor antigens. Curr Opin Immunol 1996;8:637-642.
48. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994;12:991-1045.